Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age

NCT01470287 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Hemophilus Influenzae B

Interventions

BIOLOGICAL: DTwP-HepB-Hib Vaccine

Sponsor

Novartis Vaccines